Parenteral Drugs (India) Ltd
BSE:
NSE:PDPL
PDPL Share Price
BSE:
NSE:PDPL
Pharmaceuticals
Small Cap
₹-
0 (0%)
Market Cap
₹10.11Cr
Parenteral Drugs (India) Ltd Performance
▲
▲
▲
▲
Parenteral Drugs (India) Ltd Fundamentals
Parenteral Drugs (India) Ltd Delivery and Volume
About Parenteral Drugs (India) Ltd
Parenteral Drugs (India) Limited was incorporated in 1983 as a private limited company. In 1989, the Company established their first unit to manufacture I V Fluids in Polypropylene containers with a capacity of 18 lakh bottles per annum. In March 1994, the company was converted into a public limited
| Name | Designation |
|---|---|
| Manoharlal Gupta | Chairman |
| Govind Das Garg | Whole-time Director |
| Dharam Pal Khanna | Independent Director |
| Dilip Kumar Sinha | Independent Director |
| Anil Mittal | Non Executive Director |
| Manish Verma | Independent Director |
| Vinod Kumar Gupta | Managing Director & CFO |
| Deepali Garhewal | Independent Director |
| Chhaya Gupta | Independent Director |
News and Events...
Top Gainers Today
View All
Top Losers Today
View All
Parenteral Drugs (India) Ltd FAQs
How do I Buy Parenteral Drugs (India) Ltd Shares?
By opening a demat account and having your KYC papers confirmed online, you may simply purchase Parenteral Drugs (India) Ltd shares in BlinkX.
What is the Share Price of Parenteral Drugs (India) Ltd?
The share price of any stock is volatile and changes during the day due to a variety of variables. Parenteral Drugs (India) Ltd's share price is ₹2.9 as of 2024-12-26.
What is the PE ratio of Parenteral Drugs (India) Ltd?
Parenteral Drugs (India) Ltd's P/E ratio is - times as of 2024-12-26.
What is the PB ratio of Parenteral Drugs (India) Ltd?
Parenteral Drugs (India) Ltd's most recent financial reports indicate a price-to-book ratio of -, showing the company's stock market valuation in relation to the value of its real assets.
What is the Market Cap of Parenteral Drugs (India) Ltd?
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Parenteral Drugs (India) Ltd's market capitalization is ₹10.11 Cr as on 2024-12-26.
What is the ROE of Parenteral Drugs (India) Ltd?
The current financial records of Parenteral Drugs (India) Ltd show a -% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
What is the Total Asset of Parenteral Drugs (India) Ltd?
According to Parenteral Drugs (India) Ltd's most recent financial filings, the company has a total asset value of ₹233.18, which includes current and non-current assets such as inventory, cash, properties, and equipment.
What is the 52-week high and Low of Parenteral Drugs (India) Ltd?
The 52-week high/low price of a Parenteral Drugs (India) Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Parenteral Drugs (India) Ltd's 52-week high and low as of 2024-12-26 are ₹2.9 and ₹2.7, respectively.
